CD2 and neoplasm: High CD2 expression enhances CTL recognition and cytotoxicity toward tumor cells, whereas CD2 downregulation suppresses CTL proliferation and effector function, compromises immune surveillance, and promotes tumor cell proliferation, migration, and invasion.